InfuSystem Holdings (INFU) Receivables (2010 - 2026)
InfuSystem Holdings (INFU) posted Receivables of $24.0 million for Q1 2026, up 4.71% on a QoQ basis from $22.9 million in Q4 2025, and little changed year-over-year from $23.9 million in Q1 2025.
InfuSystem Holdings (INFU) Receivables (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Receivables history runs 17 years deep, the most recent figure standing at $24.0 million for Q1 2026.
- Quarterly Receivables changed 0.37% year-over-year to $24.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.0 million (changed 0.37% YoY) and the FY2025 annual result came in at $22.9 million, up 8.02% from the prior year.
- Receivables was $24.0 million for Q1 2026 at InfuSystem Holdings, up from $22.9 million in the prior quarter.
- Across five years, Receivables topped out at $24.5 million in Q2 2025 and bottomed at $15.8 million in Q2 2022.
- A 5-year average of $20.4 million and a median of $20.5 million in 2024 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables gained 20.75% — and 2026, when it climbed 0.37%.
- InfuSystem Holdings' Receivables stood at $16.9 million in 2022, then gained by 17.54% to $19.8 million in 2023, then gained by 6.91% to $21.2 million in 2024, then gained by 8.02% to $22.9 million in 2025, then grew by 4.71% to $24.0 million in 2026.
- Business Quant data shows INFU's Receivables at $24.0 million in Q1 2026, $22.9 million in Q4 2025, and $24.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 23.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.98 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 24.31 Mn |
| Jun 30, 2025 | 24.48 Mn |
| Mar 31, 2025 | 23.89 Mn |
| Dec 31, 2024 | 21.20 Mn |
| Sep 30, 2024 | 22.76 Mn |
| Jun 30, 2024 | 21.33 Mn |
| Mar 31, 2024 | 20.54 Mn |
| Dec 31, 2023 | 19.83 Mn |
| Sep 30, 2023 | 19.46 Mn |
| Jun 30, 2023 | 18.87 Mn |
| Mar 31, 2023 | 18.27 Mn |
| Dec 31, 2022 | 16.87 Mn |
| Sep 30, 2022 | 16.11 Mn |
| Jun 30, 2022 | 15.84 Mn |
| Mar 31, 2022 | 16.39 Mn |
| Dec 31, 2021 | 15.41 Mn |
| Sep 30, 2021 | 15.85 Mn |
| Jun 30, 2021 | 15.53 Mn |